What companies are BIOVF's competitors?

Swedish Orphan Biovitrum AB (publ) (BIOVF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does BIOVF compare to its peers?

The peer comparison table on this page shows Swedish Orphan Biovitrum AB (publ) (BIOVF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does BIOVF operate in?

Swedish Orphan Biovitrum AB (publ) (BIOVF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIOVF

Swedish Orphan Biovitrum AB (publ)

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$49.03$0.00+0.00%

Market cap$17.03B·Market closed·Jul 20 8:00 PM UTC

Frequently Asked Questions About BIOVF

What companies are BIOVF's competitors?: Swedish Orphan Biovitrum AB (publ) (BIOVF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIOVF compare to its peers?: The peer comparison table on this page shows Swedish Orphan Biovitrum AB (publ) (BIOVF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIOVF operate in?: Swedish Orphan Biovitrum AB (publ) (BIOVF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

BIOVF

Swedish Orphan Biovitrum AB (publ)

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$49.03$0.00+0.00%

Market cap$17.03B·Market closed·Jul 20 8:00 PM UTC

Peers


ERFSF	Eurofins Scientific SE	$81.23	$14.1B
CSPCY	CSPC Pharmaceutical Group Limited	$4.25	$12.1B
RCDTF	Recordati S.p.A.	$58.00	$11.8B
ORINF	Orion Oyj	$82.75	$11.7B
CHJTF	CSPC Pharmaceutical Group Limited	$0.98	$11.2B
BDUUY	Bangkok Dusit Medical Services Public Company Limited	$23.41	$9.3B
ESAIY	Eisai Co., Ltd.	$6.88	$7.8B
ESALF	Eisai Co., Ltd.	$26.18	$7.4B
GIFLF	Grifols, S.A.	$10.25	$7.0B
SFOSF	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	$2.20	$5.8B

Frequently Asked Questions About BIOVF

What companies are BIOVF's competitors?: Swedish Orphan Biovitrum AB (publ) (BIOVF)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does BIOVF compare to its peers?: The peer comparison table on this page shows Swedish Orphan Biovitrum AB (publ) (BIOVF) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does BIOVF operate in?: Swedish Orphan Biovitrum AB (publ) (BIOVF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.